Yes, meaning that I think the answer is that at the end of the day patients go through their diseases. Our objective at Amgen is to make sure we find solutions for these very severe patients. That doesn't mean the solutions we are going to come up with are going to help everybody, but it is our mission statement to make sure we provide alternative approaches to very severe diseases. And by doing that you're giving physicians and patients more options.
I think especially in the area of cancer, in the area of rheumatoid arthritis, in the area of kidney disease, there are too many times that the physician has to say there's nothing more we can do, while in other countries around the world there are still other things that can be tried. I think we want to make sure that Canadians have the same opportunity as patients with these very debilitating diseases have in the rest of the world. It is their right, from my point of view, to get that same option that potentially could make a difference from a quality- or a quantity-of-life point of view.